The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | |||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | ||||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | FIGI | (to the nearest dollar) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| AMARIN CORP PLC | SPONS ADR NEW | 023111206 | 21,620,042 | 24,850,623 | SH | SOLE | 24,850,623 | 0 | 0 | |||
| BIOCRYST PHARMACEUTICALS INC | COM | 09058V103 | 5,990,000 | 1,000,000 | SH | SOLE | 1,000,000 | 0 | 0 | |||
| BIOGEN INC | COM | 09062X103 | 166,389,110 | 643,000 | SH | SOLE | 643,000 | 0 | 0 | |||
| GILEAD SCIENCES INC | COM | 375558103 | 87,118,154 | 1,075,400 | SH | SOLE | 1,075,400 | 0 | 0 | |||
| INNOVIVA INC | COM | 45781M101 | 116,723,080 | 7,277,000 | SH | SOLE | 7,277,000 | 0 | 0 | |||
| IRONWOOD PHARMACEUTICALS INC | COM CL A | 46333X108 | 187,501,600 | 16,390,000 | SH | SOLE | 16,390,000 | 0 | 0 | |||
| NEUROCRINE BIOSCIENCES INC | COM | 64125C109 | 61,927,200 | 470,000 | SH | SOLE | 470,000 | 0 | 0 | |||
| REGULUS THERAPEUTICS INC | COM | 75915K309 | 237,034 | 185,183 | SH | SOLE | 185,183 | 0 | 0 | |||
| VOR BIOPHARMA INC | COM | 929033108 | 1,390,500 | 618,000 | SH | SOLE | 618,000 | 0 | 0 | |||